Shenshen Wu

Correction: CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer Correction Open access Published: 02 April 2024 Molecular Cancer volume 23, Article number: 69 (2024) Cite this article The Original Article was published on 23 January 2020 Correction: Mol Cancer 19, 13 (2020) The authors are writing to request correction to the following paper published in Molecular Cancer [1]. They found Fig.

Although therapeutic targets have been developed for colorectal cancer (CRC) therapy, the therapeutic effects are not ideal and the survival rate for CRC patients remains poor. Therefore, it is crucial to recognize a specific target and develop an efficacious delivery system for CRC therapy. Herein, we demonstrate that reduced ALKBH5 mediates aberrant m6A modification and tumor progression in CRC.

Population and Prevention Science Shenshen Wu, Hao Sun, Yajie Wang, Xi Yang, Qingtao Meng, Hongbao Yang, Haitao Zhu, Weiyan Tang, Xiaobo Li, Michael Aschner and Rui Chen DOI: 10.1158/0008-5472.CAN-19-0773 Published October 2019 Abstract Metastasis associated with lung adenocarcinoma transcript-1 (MALAT1) is an evolutionarily highly conserved lncRNA that contributes to colorectal cancer development.